Allogene Therapeutics, Inc.
ALLO
$2.22
$0.073.26%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -14.45% | -13.50% | -38.57% | -27.24% | -34.82% |
| Total Receivables | -21.05% | -25.00% | -15.00% | 35.29% | 11.76% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -32.97% | -36.08% | -25.35% | 4.87% | 3.35% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -15.04% | -14.35% | -38.17% | -26.25% | -33.92% |
|
|
|||||
| Total Current Assets | -15.04% | -14.35% | -38.17% | -26.25% | -33.92% |
| Net Property, Plant & Equipment | -14.12% | -13.65% | -19.70% | -20.79% | -19.56% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11.97% | -0.81% | -1.46% | 118.97% | 97.62% |
| Total Assets | -24.20% | -25.35% | -27.25% | -13.37% | -14.64% |
|
|
|||||
| Total Accounts Payable | -20.84% | -32.82% | -62.50% | -12.48% | -8.53% |
| Total Accrued Expenses | -18.14% | 2.29% | 11.20% | -4.23% | -1.97% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 9.31% | 8.38% | 7.41% | 10.12% | 10.83% |
| Total Finance Division Other Current Liabilities | 123.60% | -- | -- | -- | -55.83% |
| Total Other Current Liabilities | 123.60% | -- | -- | -- | -55.83% |
| Total Current Liabilities | -8.47% | -2.27% | -15.09% | -2.82% | -4.20% |
|
|
|||||
| Total Current Liabilities | -8.47% | -2.27% | -15.09% | -2.82% | -4.20% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.85% | -9.40% | -8.91% | -8.57% | -5.77% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 103.63% | 101.87% | 100.19% | 117.96% | 49.86% |
| Total Liabilities | -2.50% | -0.74% | -4.41% | -1.92% | -3.12% |
|
|
|||||
| Common Stock & APIC | 2.72% | 2.86% | 2.97% | 8.39% | 8.03% |
| Retained Earnings | -10.49% | -12.05% | -13.99% | -15.51% | -16.49% |
| Treasury Stock & Other | 402.25% | 49.68% | 94.23% | 104.64% | 90.68% |
| Total Common Equity | -30.71% | -32.00% | -33.10% | -16.47% | -17.58% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -30.71% | -32.00% | -33.10% | -16.47% | -17.58% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -30.71% | -32.00% | -33.10% | -16.47% | -17.58% |
|
|
|||||